Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
PNQkT669cuEesKyW